[Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones].
Testosterone, FSH and LH were measured in serum of patients suffering from prostatic carcinoma. The efficacy of treatment with 1 mg diethylstilbestrol/d (Cyren A) was shown by suppressed serum levels of testosterone, FSH and LH comparable to castration in a follow-up until 560 weeks after beginning of therapy. Prolactin was raised in all patients under treatment.
D004054:Diethylstilbestrol / Q000627:therapeutic use*; D005640:Follicle Stimulating Hormone / Q000097:blood; D006062:Gonadotropins / Q000097:blood*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D011388:Prolactin / Q000097:blood; D011471:Prostatic Neoplasms / Q000628:therapy*; D013739:Testosterone / Q000097:blood*
D006062:Gonadotropins; D013739:Testosterone; D004054:Diethylstilbestrol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Testosteron-, FSH- und LH-Spiegel im Serum bei Patienten mit Prostatakarzinom unter Behandlung mit weiblichen Hormonen.